Form 4: Editas Medicine CEO Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Editas Medicine CEO, Gilmore O'Neill, sold 1,618 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

  • Editas Medicine CEO, Gilmore O'Neill, sold 1,618 shares of common stock on December 3, 2024, at a weighted average price of $2.0774 per share.
  • The sale was executed automatically under a pre-arranged sales plan adopted on April 13, 2022.
  • The transaction was necessary to cover tax withholding obligations resulting from the vesting of restricted stock units on December 2, 2024.
  • Following the transaction, O'Neill directly owns 312,106 shares of Editas Medicine common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

  • Sales of shares by executives to cover tax obligations are a common practice across the industry.
  • Many companies use similar automatic sales plans to manage these transactions.
  • The number of shares sold is relatively small compared to the total shares owned by the CEO, which is typical for these types of transactions.

Stakeholder Impact

  • The sale is unlikely to have a significant impact on shareholders as it is a routine transaction.

Key Dates

DateDescription
2022-04-13Date the automatic sales plan was adopted by the reporting person.
2024-12-02Date of vesting of restricted stock units that triggered the tax obligations.
2024-12-03Date of the stock sale.
2024-12-05Date of signature of the form.

Keywords

Editas Medicine, Gilmore O'Neill, stock sale, insider trading, tax obligations, restricted stock units, automatic sales plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.